• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

着色芽生菌病:来自中国东部的一组病例。

Chromoblastomycosis: A case series from Eastern China.

机构信息

Department of Dermatology, Hangzhou Third People's Hospital, Affiliated Hangzhou Dermatology Hospital, Zhejiang University School of Medicine, Hangzhou, China.

出版信息

PLoS Negl Trop Dis. 2022 Sep 26;16(9):e0010800. doi: 10.1371/journal.pntd.0010800. eCollection 2022 Sep.

DOI:10.1371/journal.pntd.0010800
PMID:36155495
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9536625/
Abstract

Chromoblastomycosis (CBM) is a chronic fungal infection of the cutaneous and subcutaneous tissues caused by brown pigmented fungi. Fonsecaea monophora is one of the most common pathogens of CBM in China. Most formal cases have been reported from Southern China, however, the infection is not uncommon in Eastern China where very few case series are available. To describe the clinical aspects of CBM, we report a series of 11 cases between 2018 and 2021 at a single medical center in Eastern China. The patients were predominately male (n = 9) and the disease duration ranged from 3 months to 20 years. Plaque type lesions were the most common clinical manifestations. There were 7 cases of mild forms and 3 cases of severe forms. Among the 3 severe cases, one case gave up treatment due to economic poverty; one case did not respond to a 1-year systemic treatmen; one case was cured by combination therapy of 10 months. Other cases were cured by treatment with antifungal agents. All cases of direct mycological examination were positive. All isolates were identified by morphology and sequencing of the the ITS regions of ribosomal DNA, Ten were F. monophora and 1 was Cladophialophora carrionii. All cases had been evaluated at other clinics, where 8 cases were misdiagnosed as other diseases. As a neglected tropical disease (NTD), CBM is still a major challenge in the field of dermatology, especially in its severe clinical forms. As an effective and simple diagnostic method of CBM, direct microscopic examination should be further promoted in rural hospitals.

摘要

着色芽生菌病(CBM)是一种由棕色色素真菌引起的皮肤和皮下组织的慢性真菌感染。单端孢霉是中国 CBM 的最常见病原体之一。大多数确诊病例都来自中国南方,但在中国东部,这种感染并不罕见,然而,那里很少有病例系列报告。为了描述 CBM 的临床特征,我们报告了 2018 年至 2021 年期间在华东地区一家医疗中心的 11 例病例系列。患者主要为男性(n = 9),疾病持续时间从 3 个月到 20 年不等。斑块型病变是最常见的临床表现。有 7 例为轻度,3 例为重度。在 3 例重度病例中,1 例因经济贫困而放弃治疗;1 例对 1 年的系统治疗无反应;1 例经 10 个月的联合治疗治愈。其他病例经抗真菌药物治疗治愈。所有直接真菌学检查均为阳性。所有分离株均通过形态学和核糖体 DNA 的 ITS 区序列鉴定,10 株为单端孢霉,1 株为拟卡利奥皮拉氏菌。所有病例均在其他诊所进行了评估,其中 8 例被误诊为其他疾病。作为一种被忽视的热带病(NTD),CBM 仍然是皮肤科领域的一个主要挑战,特别是在其严重的临床形式。作为 CBM 的一种有效且简单的诊断方法,直接显微镜检查应在农村医院进一步推广。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54f3/9536625/bd83e2efb483/pntd.0010800.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54f3/9536625/453a6604e8cb/pntd.0010800.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54f3/9536625/b127d0d9e91d/pntd.0010800.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54f3/9536625/96137b59810a/pntd.0010800.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54f3/9536625/bd83e2efb483/pntd.0010800.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54f3/9536625/453a6604e8cb/pntd.0010800.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54f3/9536625/b127d0d9e91d/pntd.0010800.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54f3/9536625/96137b59810a/pntd.0010800.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54f3/9536625/bd83e2efb483/pntd.0010800.g004.jpg

相似文献

1
Chromoblastomycosis: A case series from Eastern China.着色芽生菌病:来自中国东部的一组病例。
PLoS Negl Trop Dis. 2022 Sep 26;16(9):e0010800. doi: 10.1371/journal.pntd.0010800. eCollection 2022 Sep.
2
Chromoblastomycosis caused by Fonsecaea monophora in Mexico.墨西哥单孢瓶霉引起的着色芽生菌病。
J Mycol Med. 2021 Jun;31(2):101114. doi: 10.1016/j.mycmed.2021.101114. Epub 2021 Jan 19.
3
Chromoblastomycosis in Taiwan: A report of 30 cases and a review of the literature.台湾地区的着色芽生菌病:30例报告及文献综述
Med Mycol. 2018 Jun 1;56(4):395-405. doi: 10.1093/mmy/myx075.
4
Chromoblastomycosis due to Fonsecaea monophora in a man with nephritic syndrome.由单端孢霉引起的暗色丝孢霉病于肾病综合征患者。
Mycopathologia. 2015 Jun;179(5-6):447-52. doi: 10.1007/s11046-014-9856-z. Epub 2015 Jan 10.
5
A case of relapsed chromoblastomycosis due to Fonsecaea monophora: antifungal susceptibility and phylogenetic analysis.由单端孢霉引起的复发性着色芽生菌病 1 例:抗真菌药敏试验和系统发育分析。
Mycopathologia. 2013 Aug;176(1-2):139-44. doi: 10.1007/s11046-013-9660-1. Epub 2013 May 4.
6
Molecular diversity of Fonsecaea (Chaetothyriales) causing chromoblastomycosis in southern China.在中国南方引起着色芽生菌病的瓶霉属(座囊菌目)的分子多样性
Med Mycol. 2009 Feb;47(1):27-33. doi: 10.1080/13693780802468209. Epub 2008 Oct 25.
7
Treatment responses in patients with chromoblastomycosis to itraconazole in Madagascar.马达加斯加地区曲菌病患者应用伊曲康唑治疗的反应。
Med Mycol. 2022 Nov 12;60(11). doi: 10.1093/mmy/myac086.
8
Endemic Chromoblastomycosis Caused Predominantly by Fonsecaea nubica, Madagascar.马达加斯加主要由拟青霉引起的地方性着色芽生菌病。
Emerg Infect Dis. 2020 Jun;26(6):1201-1211. doi: 10.3201/eid2606.191498.
9
Successful treatment of chromoblastomycosis of 36 years duration caused by Fonsecaea monophora.成功治疗由单端孢霉引起的 36 年病程的着色芽生菌病。
Med Mycol. 2010 Mar;48(2):390-3. doi: 10.1080/13693780903008813.
10
Molecular Characteristics of Regional Chromoblastomycosis in Guangdong, China: Epidemiological, Clinical, Antifungal Susceptibility, and Serum Cytokine Profiles of 45 Cases.中国广东地区区域性着色芽生菌病的分子特征:45 例的流行病学、临床、抗真菌药敏和血清细胞因子谱。
Front Cell Infect Microbiol. 2022 Feb 18;12:810604. doi: 10.3389/fcimb.2022.810604. eCollection 2022.

引用本文的文献

1
Quality of Life, Disability, and Fungal Neglected Tropical Diseases.生活质量、残疾与真菌性被忽视热带病
Curr Fungal Infect Rep. 2025 Apr;19(1). doi: 10.1007/s12281-025-00503-0.
2
Bridging gaps in the elimination of deep mycoses: a comparative analysis of mycetoma and chromoblastomycosis control strategies in Rwanda and China.弥合深部真菌病消除工作中的差距:卢旺达和中国足菌肿与着色芽生菌病控制策略的比较分析
Trop Med Health. 2025 Aug 25;53(1):115. doi: 10.1186/s41182-025-00778-6.
3
Development of PCR-Multiplex Assays for Identification of the Herpotrichiellaceae Family and Agents Causing Chromoblastomycosis.

本文引用的文献

1
Clinical aspects of previously treated chromoblastomycosis: A case series from Madagascar.既往治疗过的着色芽生菌病的临床方面:来自马达加斯加的病例系列。
Int J Infect Dis. 2020 Dec;101:228-232. doi: 10.1016/j.ijid.2020.09.1479. Epub 2020 Oct 2.
2
Chromoblastomycosis Caused by Fonsecaea nubica: First Report in Northern China and Literature Review.中国北方首例中国被毛孢引起的着色芽生菌病:病例报告及文献复习
Mycopathologia. 2019 Feb;184(1):97-105. doi: 10.1007/s11046-018-0307-0. Epub 2018 Dec 13.
3
Chromoblastomycosis: an etiological, epidemiological, clinical, diagnostic, and treatment update.
用于鉴定瓶霉科及引起着色芽生菌病病原体的聚合酶链反应多重检测方法的开发
J Fungi (Basel). 2024 Aug 4;10(8):548. doi: 10.3390/jof10080548.
4
Chromoblastomycosis in French Guiana: Epidemiology and Practices, 1955-2023.法属圭亚那的着色芽生菌病:1955年至2023年的流行病学与诊疗情况
J Fungi (Basel). 2024 Feb 22;10(3):168. doi: 10.3390/jof10030168.
5
Identification of Chromoblastomycosis and Phaeohyphomycosis Agents through ITS-RFLP.通过ITS-RFLP鉴定着色芽生菌病和暗色丝孢霉病病原体
J Fungi (Basel). 2024 Feb 18;10(2):159. doi: 10.3390/jof10020159.
着色芽生菌病:病因学、流行病学、临床、诊断及治疗的最新进展
An Bras Dermatol. 2018 Jul-Aug;93(4):495-506. doi: 10.1590/abd1806-4841.20187321.
4
Sporotrichosis: an update on epidemiology, etiopathogenesis, laboratory and clinical therapeutics.孢子丝菌病:流行病学、病因发病机制、实验室检查及临床治疗的最新进展
An Bras Dermatol. 2017 Sep-Oct;92(5):606-620. doi: 10.1590/abd1806-4841.2017279.
5
Chromoblastomycosis in Taiwan: A report of 30 cases and a review of the literature.台湾地区的着色芽生菌病:30例报告及文献综述
Med Mycol. 2018 Jun 1;56(4):395-405. doi: 10.1093/mmy/myx075.
6
Photodynamic effects on Fonsecaea monophora conidia and RAW264.7 in vitro.光动力效应对外瓶霉孢子和 RAW264.7 细胞的体外影响。
J Photochem Photobiol B. 2017 Nov;176:112-117. doi: 10.1016/j.jphotobiol.2017.09.001. Epub 2017 Sep 18.
7
Molecular identification of chromoblastomycosis clinical isolates in Guangdong.
Med Mycol. 2017 Nov 1;55(8):896. doi: 10.1093/mmy/myx093.
8
Chromoblastomycosis in India: Review of 169 cases.印度的着色芽生菌病:169例病例回顾
PLoS Negl Trop Dis. 2017 Aug 3;11(8):e0005534. doi: 10.1371/journal.pntd.0005534. eCollection 2017 Aug.
9
Chromoblastomycosis.着色芽生菌病
Clin Microbiol Rev. 2017 Jan;30(1):233-276. doi: 10.1128/CMR.00032-16.
10
Clinical and demographic profile of chromoblastomycosis in a referral service in the midwest of São Paulo state (Brazil).巴西圣保罗州中西部一家转诊机构中着色芽生菌病的临床和人口统计学特征
An Bras Dermatol. 2015 Jan-Feb;90(1):140-2. doi: 10.1590/abd1806-4841.20153252.